Want to see NBTX full AI Analyst Report?
Nanobiotix (NBTX) Income Statement
Nanobiotix Income Statement
Last quarter (Q2 2026), Nanobiotix's total revenue was $5.55M, a decrease of 40.24% from the same quarter last year. In Q2, Nanobiotix's net income was $-34.75M. See Nanobiotix’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 29.64M | $ -7.19M | $ 36.21M | $ 4.78M | $ 2.65M | |
| $ 29.64M | $ -7.19M | $ 36.21M | $ 4.78M | $ 2.65M | |
| $ 40.46M | $ 61.20M | $ 62.99M | $ 51.48M | $ 55.23M | |
| Depreciation and Amortization | $ 1.50M | $ 1.62M | $ 1.51M | $ 1.50M | $ 1.56M |
| $ -12.07M | $ -66.64M | $ -22.72M | $ -44.22M | $ -45.60M | |
| $ -10.82M | $ -68.39M | $ -26.78M | $ -46.70M | $ -52.58M | |
| $ -13.14M | $ 361.00K | $ -12.80M | $ -10.33M | $ 5.58M | |
| $ -23.96M | $ -68.03M | $ -39.58M | $ -57.03M | $ -47.00M | |
| $ -23.96M | $ -68.13M | $ -39.70M | $ -57.04M | $ -47.00M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.50 | $ -1.44 | $ -1.08 | $ -1.64 | $ -1.35 |
| Diluted EPS | $ -0.50 | $ -1.44 | $ -1.08 | $ -1.64 | $ -1.35 |
| Weighted Average Shares Outstanding | 47.82M | 47.27M | 36.76M | 34.85M | 34.73M |
| Weighted Average Shares Outstanding (Diluted) | 47.82M | 47.27M | 36.93M | 34.85M | 34.73M |
Currency in EUR
